Price Table

* Prices are based on daily market changes.
DateOpenHighLowCloseVolumeDelivery %20-Day sma50-Day sma200-Day sma
Day High Low Range
Past Performance & Moving Averages
Day’sLow high rangeSMAStock performanceNifty performance
Trend Analysis
Key Data
Market capBook valuestock p/eDividend yieldroceroesales growth (3Y)face value (3Y)

Glaxosmithkline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd. or GSK Rx India was established in 1924 in India. It is one of the oldest pharmaceutical companies and employs over 3,500 people. Globally, the company is around £28.4 billion, and it is leading research-based healthcare and pharmaceutical companies. In India, it is one of the market leaders with an approximate turnover of INR 2080 crore and a share of 5.1%. The Company is also one of the world's leading research-based pharmaceutical and healthcare companies. It is committed to enhancing the quality of human life by enabling people to do more, feel better, and live longer. The company leads in many therapeutic segments such as dermatology, anti–hermeneutics, and hormones. It has 7 products in the top 50 brands, and the top five GSK products are Augmentin, Calpol, Ceftum, Phexin, and Betnesol. The company's vaccines division is ranked first in a fast-growing vaccines market. Some leading products in India are Havrix, Varilrix, Rotarix, Hiberix, and Cervarix. GSK India's R&D centers at Thane and Nashik have been granted recognition by the Department of Scientific and Industrial Research, Government of India. The number of clinical studies conducted in India is rapidly growing across a range of therapy areas. The company's social responsibility programs focus on the development of underdeveloped villages, women, children, and age, specifically in the areas of healthcare and education. The GSK India product portfolio also includes prescription medicines and vaccines, and prescription medicines also range across therapeutic areas. It includes anti-infectives, dermatology, gynecology, diabetes, cardiovascular disease, oncology, and respiratory diseases. The GSK India is the market leader in the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. The company's best–in–class field force, backed by a nationwide network of stockiest, ensures that the Company's products are readily available across the nation. The company also has 2 manufacturing units in India that are located at Nashik and Thane as well as a clinical development center in Bangalore. Also, the state of art plant at Nashik makes formulations while bulk drugs and the active pharmaceutical ingredients are manufactured at Thane.


Prescription medicines The GSK India product portfolio includes prescription medicines and vaccines and it is also a market leader in most of the prescription medicines such as:
  • Analgesic
  • Anti–Infective
  • Anti–Inflammatory
  • Anti–Parasitic
  • Cardiovascular
  • Dermatology
  • Diabetes
  • Endocrine
  • Gastrointestinal
  • Gynecology
  • Immunosuppressants
  • Nutritional
  • Respiratory
  • CNS
  • Oncology


The company's vaccines division is one of the leaders in the fast-growing vaccine market. It provides vaccines for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, and others. Also, brands such as Engerix–B, Havrix, Priorix, and Twinrix are some vaccines that are created by GSK India. The company was awarded the “Multi-Cultural Diversity Award” from GlaxoSmithKline Consumer Healthcare, the US as an appreciation for the ‘Family Vaccines’ Programme. Also in 2008, the company launched two vaccines for diphtheria, tetanus and a cellular pertussis (DTP) namely Boostrix and Infanrix. The DTP vaccines are part of the routine immunization in over 100 developed as well as developing countries. The vaccine Infanrix is used for childhood immunization against Diphtheria, Tetanus, and Pertussis for newborns it's the sixth week of age. And the boostrix is used for children above seven years of age, and adolescents, and adults for boosting the waning immunity against Diphtheria, Tetanus, and Pertussis.


  • 2010:
  • Launches Mycamine an injectible antifungal drug that is in-licensed from Astellas, Japan.
  • Andrew Witty dedicates the Albendazole facility located at Nashik to the WHO to eliminate Lymphatic. Also, FilariasisCertificate of Merit awarded to the Ankleshwar Factory for 'Excellence in Energy Conservation' by the Federation of Gujarat Mills and Industries or FGMI.
  • Voluntary Retirement Scheme introduced for Glaxo workers.
  • Eskayef Limited was renamed as SmithKline Beecham Pharmaceuticals India Ltd.
  • The Mysore plant received the ISO 9002 certification.
  • And the new Iodex plant was being inaugurated in Bangalore.
  • 2011:
  • The Most Respected Company Award – Business World
  • Launched Votrient that indicated for the treatment of advanced renal cell carcinoma (RCC).
  • Launched Revolade indicated for the treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
  • The Vaccine Market Company of the Year award – Frost & Sullivan.
  • The Special Commendation – Good Corporate Citizen Award 2011 - Bombay Chamber of Commerce.
  • Pharma/Life – The Science Supply Chain Excellence Award is presented at the 5thExpress, Logistics, and Supply Chain Conclave.
  • Unveils Synflorix – it is a vaccine against invasive pneumococcal disease.
  • 2012:
  • Launched Altargo used to treat bacterial infections affecting small areas of skin.
  • Introduced Volibris (Ambrisentan), a non–sulphonamide class endothelin receptor antagonist (ERA) used for treating pulmonary arterial hypertension (PAH) indicated for WHO Functional Class II & III patients in India. Also, Volibris is a trademark of GlaxoSmithKline and Ambrisentan has been licensed to GlaxoSmithKline by Gilead Sciences Inc.
  • GSK India is also named as India's most admired company in Pharmaceutical space by the HAY Group and Fortune Magazine.
  • Awarded the Pediatrician's Award for the Best Vaccine Company of the Year by the Frost & Sullivan.
  • Also, received the Dr. H. R. Nanji Memorial Marketing Excellence Award for the CCM in the 'Existing Pharmaceuticals Product' segment from OPPI or Organisation of Pharmaceutical Producers of India.
  • 2013:
  • Received the Fourth CII National HR Excellence Award 2013 for 'Significant Achievement in the HR Excellence.'
  • GSK India is named as one of 'India's Most Admired Companies' by Fortune India & HAY Group.
  • Business Today surveyed in partnership with PeopleStrong HR Services named GSK India as one of the 'Best Companies to Work for.’

Trading and Investment Terminology